Model Proves Miners Need Bitcoin Above $74K to Break Even
A new Bitcoin mining cost model, tested with Riot Platforms data, finds power costs can be covered only at a BTC pric...
Which Indices Serve As Benchmarks
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,608 articles
If the Fed Cuts Again, IEFA Could Rally Further
Investors watch for another Fed rate cut as IEFA shows resilience. This article outlines key data and signals to moni...
Bitcoin Traders Focus $61K as Oil Surges Past $115
Bitcoin hovered near the $61,000 level as oil surged above $115 and a softer-than-expected jobs report renewed inflat...
JEPQ’s 0.35% Hides a 9-Point Gap in Income Returns
A closer look at JEPQ reveals a persistent gap between monthly income and total returns. The premium income ETF pays ...
Real Brokerage Adds Diego Leader to Chief Growth Officer
The Real Brokerage is expanding its leadership with the appointment of Jason Cassity as Chief Growth Officer, a move ...
Group Launches Japan’s First Trust-Backed Stablecoin JPYSC
SBI Group introduces JPYSC, a trust-bank-backed stablecoin pegged to the yen. Access is limited to SBI VC Trade custo...
Growth Stock Down Right: A 21% Buy Opportunity for 2026
When a promising growth stock pulls back 21% from its recent high, many investors hesitate. This guide shows how to v...
Could SVOL’s High Yield Backfire in 2026? A Closer Look
SVOL offers a sizzling income stream, but the hidden tail risks tied to volatility bets are real. This piece weighs c...
Cramer Warns Investors: Those Margins Draw Google Threats
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
Ferdinand’s Tate Returns Kate: Blended Family Chat
Tate Ferdinand makes a candid return to Kate Ferdinand’s Blended podcast to talk about life inside a blended family. ...
Bitcoin Once Surged 2,200%: A Fresh Macro Signal for BTC
Bitcoin now faces a fresh macro signal after Quantitative Tightening ended in late 2025. Analysts highlight bounce po...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status